Literature DB >> 28107044

Quercetin Attenuates Cell Survival, Inflammation, and Angiogenesis via Modulation of AKT Signaling in Murine T-Cell Lymphoma.

Akhilendra Kumar Maurya1, Manjula Vinayak1.   

Abstract

AKT signaling is important to maintaining normal physiology. Hyperactivation of AKT signaling is frequent in cancer, which maintains a high oxidative state in a tumor microenvironment that is needed for tumor adaptation. Therefore, antioxidants are proposed to exhibit anticancer properties by interfering with the tumor microenvironment. Quercetin is an ubiquitous bioactive antioxidant rich in vegetables and beverages. The present study aimed to analyze cancer preventive property of quercetin in ascite cells of Dalton's lymphoma-bearing mice. Protein level was determined by Western blotting. Nitric oxide (NO) level was estimated spectrophotometrically using Griess reagent. Results show downregulation in phosphorylation of AKT and PDK1 by quercetin, which was consistent with decreased phosphorylation of downstream survival factors such as BAD, GSK-3β, mTOR, and IkBα. Further, quercetin attenuated the levels of angiogenic factor VEGF-A and inflammatory enzymes COX-2 and iNOS as well as NO levels, whereas it increased the levels of phosphatase PTEN. Overall results suggest that quercetin modulates AKT signaling leading to attenuation of cell survival, inflammation, and angiogenesis in lymphoma-bearing mice.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28107044     DOI: 10.1080/01635581.2017.1267775

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  7 in total

1.  Quercetin Can Inhibit Angiogenesis via the Down Regulation of MALAT1 and MIAT LncRNAs in Human Umbilical Vein Endothelial Cells.

Authors:  Somayeh Esteghlal; Mohammad Javad Mokhtari; Zahra Beyzaei
Journal:  Int J Prev Med       Date:  2021-06-18

Review 2.  Recent development in antihyperalgesic effect of phytochemicals: anti-inflammatory and neuro-modulatory actions.

Authors:  Ajeet Kumar Singh; Sanjay Kumar; Manjula Vinayak
Journal:  Inflamm Res       Date:  2018-05-16       Impact factor: 4.575

Review 3.  Antiangiogenic Effect of Flavonoids and Chalcones: An Update.

Authors:  Ladislav Mirossay; Lenka Varinská; Ján Mojžiš
Journal:  Int J Mol Sci       Date:  2017-12-22       Impact factor: 5.923

Review 4.  Flavonoids as Anticancer Agents.

Authors:  Dalia M Kopustinskiene; Valdas Jakstas; Arunas Savickas; Jurga Bernatoniene
Journal:  Nutrients       Date:  2020-02-12       Impact factor: 5.717

5.  Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.

Authors:  Qijun Li; Yong Dong; Yubin Pan; Honglin Tang; Da Li
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

Review 6.  A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells.

Authors:  Partha Biswas; Dipta Dey; Polash Kumar Biswas; Tanjim Ishraq Rahaman; Shuvo Saha; Anwar Parvez; Dhrubo Ahmed Khan; Nusrat Jahan Lily; Konka Saha; Md Sohel; Mohammad Mehedi Hasan; Salauddin Al Azad; Shabana Bibi; Md Nazmul Hasan; Mohammed Rahmatullah; Jaemoo Chun; Md Ataur Rahman; Bonglee Kim
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

Review 7.  Quercetin as a Novel Therapeutic Approach for Lymphoma.

Authors:  Saiedeh Razi Soofiyani; Kamran Hosseini; Haleh Forouhandeh; Tohid Ghasemnejad; Vahideh Tarhriz; Parina Asgharian; Željko Reiner; Javad Sharifi-Rad; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-08-02       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.